This article discusses the relevance of indirect cost estimates for health policy and reviews the current empirical and methodological literature on this issue. The human capital approach is almost unanimously used for estimating indirect costs, defined as production loss due to disease, although a growing number of authors question its validity. Summary Indirect costs of disease often constitute a substantial part of estimated costs or savings in economic evaluations of healthcare programmes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |